DNA share
Share capital history
DNA listed its shares on Nasdaq Helsinki (the Helsinki Stock Exchange) towards the end of 2016. DNA’s shares were delisted from Nasdaq Helsinki on 3 February 2020.
DNA has one series of shares and each share entitles to one vote. DNA’s fully paid-up share capital is EUR 72,702,225.65 and the company has 132,303,500 shares.
The following table summarizes the history of DNA’s share capital:
| Number of shares outstanding | Number of treasury shares | Total number of shares | Registered | |
|---|---|---|---|---|
| 1 Jan 2013 | 8,478,532 | 1,132,144 | 9,610,676 | |
| 31 Dec 2013 | 8,478,532 | 1,132,144 | 9,610,676 | |
| Directed share issue | 601 | 601 | 11 July 2014 | |
| 31 Dec 2014 | 8,479,133 | 1,132,144 | 9,611,277 | |
| Directed share issue | 605 | 605 | 2 Jan 2015 | |
| Share subscription under the share based compensation plan | 6,475 | 6,475 | 15 Jan 2015 | |
| Transfer of treasury shares as a part of remuneration | 1,657 | (1,657) | 0 | |
| 31 December 2015 | 8,487,870 | 1,130,487 | 9,618,357 | |
| Transer of treasury shares as a part of remuneration | 520 | (520) | 0 | |
| Cancellation of treasury shares | (1,129,967) | (1,129,967) | 13 Oct 2016 | |
| Subdivision of shares (split) through share issue without payment | 118,837,460 | 118,837,460 | 27 Oct 2016 | |
| 27 Oct 2016 | 127,325,850 | 0 | 127,325,850 | |
| 30 Nov 2016 | 132,031,957 | 0 | 132,031,957 | |
| 16 Dec 2016 New shares subscribed for in the personnel offering were registered in the Trade Register | 132,303,500 | 0 | 132,303,500 | 16 Dec 2016 |
| 1 Jun 2017 Share buyback programme started | 0 | |||
| 14 Sep 2017 Share buyback programme ended | 967,897 | |||
| 4 Dec 2017 Transer of treasury shares as a part of remuneration | -703,080 | |||
| 132,303,500 | 264,817 | 4 Dec 2017 | ||
| 1 March 2018 | -82,028 | |||
| 132,303,500 | 182,789 | 1 March 2018 | ||
| 1 March 2019 | -61,473 | |||
| 132,303,500 | 121,316 | 1 March 2019 |